Cancer

11 April 2008

New drug protects against radiation

Researchers have developed a new drug that can protect healthy cells and bone marrow against anti-cancer radiation therapy and maybe even against the effects of a nuclear bomb.

0
Researchers have developed a new drug that can protect healthy cells and bone marrow against anti-cancer radiation therapy and maybe even against the effects of a nuclear bomb, a new study showed.

While radiation therapy is used effectively to destroy cancerous tumours, it can have a devastating effect on healthy cells, noted the study published in the April 11 edition of the American review Science.

But a new drug protects gastrointestinal cells and bone marrow in mice and monkeys from radiation without reducing the treatment's effectiveness, lead author Lyudmila Burdelya of New York state's Roswell Park Cancer Institute said.

Dr Richard Kolesnick, of the Memorial Sloan-Kettering Cancer Centre in New York, said the research represented "a breakthrough in an issue that has challenged the scientific community."

Findings have wide implications
Dr Preet Chaudhary, an oncologist at the University of Pennsylvania, said the work could have wide implications for the fight against cancer.

The drug, CBLB502, works by activating a well-known molecular pathway that some cancer cells use to stave off cell death, Burdelya and colleagues said.

A single dose given to the animals shortly before receiving radiation therapy significantly reduced the radiation damage caused to bone marrow and gastrointestinal cells and prolonged the animals' survival, the researchers said.

They said the drug might also be a useful protection against radiation exposure from a nuclear plant malfunction or nuclear bomb, adding that clinical trials on humans could begin this summer. – (Sapa)

April 2008

Read more:
ER patients exposed to radiation
Prostate: no risk radiation

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit cansa.org.za.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules